TGA
- Local brand name: Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)
- Status: approved
DINUTUXIMAB BETA (DINUTUXIMAB BETA) regulatory status in Australia.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. TGA has authorised it.
Marketing authorisation holder not available in our data.